AKI Biomarkers in Coronavirus(COVID)-19

NCT04408248 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-03-15

No results posted yet for this study

Summary

This research aims to investigate the role of daily measurement of urinary cell cycle arrest markers and other serum and urinary biomarkers to predict the development of acute kidney injury in critically ill patients with COVID-19 and acute respiratory disease.

Conditions

Sponsors & Collaborators

  • University Hospital Muenster

    collaborator OTHER
  • Guy's and St Thomas' NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Marlies Ostermann, MD, PhD · Guy's and St Thomas' NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-20
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04408248 on ClinicalTrials.gov